Shares soar after board recommends offer from private equity firm Triton Investment Management
The cancer drug specialist Clinigen has agreed to a £1.2bn takeover deal from a London-based investment firm, becoming the latest big British company to be taken private.
Triton Investment Management has offered to pay 883p a share for the company, whose main product is the acquired cancer medicine Proleukin.